The Greatest FDA Advisory Committees Of All Time Part IV: Neurology Lays Claim To The Crown

 
• By Ramsey Baghdadi

We look back at another of the greatest FDA advisory committees of the last 20 years. This time: the nearly 12-hour meeting in 2016 on Sarepta’s eteplirsen for Duchenne muscular dystrophy.

full conference room
The eteplirsen advisory committee meeting drew hundreds of parents, advocates, and patients, as well as national media. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers